Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

• Status: Completed
• Trial end date: 2006-02-13
• Target enrollment: 0
• Participant gender: All

Summary

A clinical study determines the safety and efficacy of sitagliptin (MK0431) in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patients Have Type 2 Diabetes Mellitus On Diet/Exercise Therapy

Exclusion Criteria:

• Patients Have Type 1 Diabetes Mellitus